Manila-Based telehealth Startup &you Secures Pre- Seed Funding from International Investors
The company is launching with a focus on some of the most neglected and misunderstood health issues in Southeast Asia. But its broader ambition is to become the region's most seamless and trusted online healthcare platform — a market expected to surpass $22 billion by 2030, growing at a CAGR of over 18%.
Opinions expressed by Entrepreneur contributors are their own.
You're reading Entrepreneur Asia Pacific, an international franchise of Entrepreneur Media.
&you (andyou.ph), a health tech startup founded by entrepreneur Emil Eriksen, has raised an undisclosed amount in pre-seed funding, backed by a strategic group of early investors in a round led by New York-based VC Everywhere Ventures.
"Despite a dynamic global trade environment, the macro tailwinds behind Southeast Asia and the Philippines in particular are unquestionable. We believe in rising prosperity, the incredible power of an expanding middle class, and the demand that creates for quality healthcare products. We are excited to be investing in the Philippines for the fifth time," said Scott Hartley, co-founder and managing partner, Everywhere Ventures.
The company is launching with a focus on some of the most neglected and misunderstood health issues in Southeast Asia. But its broader ambition is to become the region's most seamless and trusted online healthcare platform — a market expected to surpass $22 billion by 2030, growing at a CAGR of over 18%.
Rebuilding Healthcare Starts with Restoring Trust
In the Philippines, trust in the healthcare system is in short supply — and for good reason.
Ninety percent of people self-medicate, not by choice but out of necessity. Seven in ten rural patients travel hours just to see a specialist. Half of Filipinos can't reach a clinic within 30 minutes, and 50% of families face financial hardship just trying to access basic care.
For millions, traditional healthcare is either out of reach, unaffordable, or unreliable. That's the gap &you is stepping into — not just with technology, but with a new model built around clinical credibility, licensed care, and patient trust.
Tech at its core — not layered on later
While a few players already exist in the space, &you believe the current offerings fall short — especially in markets like the Philippines, where patients are often left with overpriced products, clunky apps, or worse: black-market alternatives.
&you offers licensed doctor consultations and FDA-compliant treatments through a streamlined digital platform — no clinic visits required.
&you is developing a fully localized end-to-end system — from mobile onboarding and medical intake to prescription and nationwide delivery — built specifically for Southeast Asia's infrastructure and behavior. The platform will use advanced technology to help users assess their health and connect them with licensed local doctors to create personalized treatment plans.
"We're addressing unique regional challenges such as disrupted supply chains, user- unfriendly platforms, and a significant trust deficit. Our goal is to make getting help feel as easy and safe as ordering food," said Emil Eriksen, Founder of &you.
A Homegrown Model with Global Standards
Behind the scenes, &you works only with FDA-compliant partners and fully-licensed doctors, ensuring that all treatments are not only accessible but also safe and fully regulated. The company emphasizes user experience and clinical credibility — not just cheaper medicine.
All &you orders are handled through carefully selected partners to ensure a smooth and confidential delivery experience.
Early Traction Signals Big Demand
Since launching just this April, &you has already seen rapid traction, with thousands of customers in the few month, and expects to scale quickly as awareness grows.
The new funding will be used to scale engineering, expand local operations, and prepare for entry into new verticals in the next 12 months.
"Healthcare doesn't work here the way it should," Eriksen says. "We're fixing that — one problem, one product, and one person at a time."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
39 minutes ago
- Forbes
May Jobs Report: On The Surface, It Seems Good. It's Not.
SUNRISE, FLORIDA - JUNE 26: Job seekers attends the South Florida Job Fair held at ... More the Amerant Bank Arena on June 26, 2024 in Sunrise, Florida. More than 50 companies set up booths to recruit people from entry-level to management. Open jobs include police officers, food service, security, sales reps, technicians, customer service, IT, teacher assistants, insurance agents, and account executives. (Photo by) The American job market added 139,000 jobs in May, slightly exceeding expectations of 126,000, and the unemployment rate remained at 4.2%. Good, right? No. That would be like your doctor taking a brief glance at you and declaring you're OK without checking your blood pressure, listening to your heart and lungs, or drawing blood. That's how deceptive this all is. With May now in the books, 2025 is on pace to create 1.49 million jobs, the lowest number since 2010, when we were climbing out of the Great Recession. That's barely what is needed to keep with population growth, the labor force participation rate, and the employment-population ratio. Furthermore, April's numbers have been revised downward by 30,000 to 147,000, and March and April actually created 95,000 fewer jobs than originally reported. The job market is much weaker than it initially appears. For instance, health care added 62,000 jobs in May, while leisure and hospitality created 48,000 jobs. Together, the two sectors accounted for 79% of all jobs created in May. Add the 16,000 jobs created in social assistance and we come to 90% of all jobs created in May. That kind of disproportionate growth is worrisome. A harmonious job market as a driver of a healthy economy tends to create jobs across the board, a hallmark of the job market during the previous four years, the best four-year stretch in history. Completing the picture, employment showed little change over the month in all other major industries. Federal government employment continued to decline in May by 22,000 and is down by 59,000 in 2025. Note the rising rate in May; none of us knows the real extent of this, of course, as many of the firings that DOGE perpetrated are still in flux. But so far in 2025, three out of eight job losses in the government employment sector took place in May. We can expect more job losses in this sector. All in all, not only did the civilian labor force shrink by 625,000, the ranks of the employed shrank by 696,000, and the ranks of the unemployed grew by 71,000. That's clearly an exodus; a significant number of people leaving the job market altogether. They just quit looking for work, and this amounts to overall job market shrinkage, a different measurement than job loss or creation. If the total population and the civilian non-institutional population grow, so should the labor force, or we'll face a growing inability to provide goods and services for both our domestic and international markets. That drop in the supply side capacity could fuel inflation. If it's any consolation, average hourly earnings for all employees on private nonfarm payrolls rose by 0.4%, or by 3.9%, over the past 12 months. Not only are May's numbers not what we'd like to see, the trend lines are all negative. It's not yet time to batten down the hatches, but it is time to make sure our ship is seaworthy.
Health Line
an hour ago
- Health Line
What's the Life Expectancy for Parkinson's Disease?
Key takeaways At age 65, patients with Parkinson's disease have a life expectancy reduced by 6.7 years compared to those without the disease, while at age 85, the difference in life expectancy is 1.2 years. Severe clinical milestones that can impact survival include visual hallucinations, recurrent falls, dementia, and placement in a nursing home. Each milestone may double the risk of death during a 10-year period. Males with Parkinson's disease may experience a greater reduction in life expectancy than females, and those diagnosed before age 70 typically see a larger decrease in life expectancy compared to later diagnoses. If you or a loved one has received a diagnosis of Parkinson's, you may be wondering how the disease may progress over time. Parkinson's disease is a slow, progressive disease. This means that symptoms gradually worsen over time. While Parkinson's disease itself isn't fatal, related complications can reduce life expectancy. The individual outlook can vary based on the severity of Parkinson's disease, a person's overall health, and the type of Parkinson's disease they have. Research from 2020 suggests that at 65 years, the life expectancy of patients with Parkinson's was reduced by 6.7 years compared to that of people without Parkinson's disease. At 85, the difference in life expectancy was 1.2 years. Keep reading to learn more about the disease course and outlook with Parkinson's disease and the factors that may inform a doctor's prediction about a person's outlook. Factors that affect the outlook with Parkinson's disease Symptoms and complications can affect the outlook of a person with Parkinson's disease. Symptoms and severity Research from 2022 suggests that the presence of certain severe clinical milestones may predict a person's disease course with Parkinson's disease and increase the risk of death. Each milestone may double the risk of death during a 10-year period. These milestones include: visual hallucinations recurrent falls dementia placement in a nursing home Parkinson's and falls Falls are a common secondary symptom of Parkinson's disease. The risk of falling increases in stages 3 and is greater in stages 4 and 5. In these stages, you may not be able to stand or walk on your own. You'll also be prone to broken bones and concussions, and severe falls can be dangerous. Complications from a serious fall can reduce your life expectancy. Age Age is another factor in the diagnosis and outlook for Parkinson's disease. Most people will receive a diagnosis after 70. As you get older, you may be more prone to falls and more likely to develop certain diseases, even if you don't have Parkinson's disease. These risks can increase if you have Parkinson's. Research from 2020 suggests that people who receive a diagnosis before age 70 usually experience a greater reduction in life expectancy: In people at age 55: a 10.1-year reduction In people at age 65: a 6.7-year reduction In people at age 75: a 3.5-year reduction In people at age 85: a 1.2-year reduction Sex Research suggests that males with Parkinson's may have a greater reduction in life expectancy than females. Access to treatment Life expectancy has increased significantly due to advances in treatment. Medications and physical and occupational therapy are especially helpful in the earliest stages of Parkinson's. These treatments can improve your quality of life. Type of disease The type of parkinsonism can also impact a person's life expectancy, according to 2020 research. People with atypical parkinsonism, including Lewy body dementia, progressive supranuclear palsy, and multiple system atrophy, have increased mortality compared to people with typical Parkinson's disease and people without Parkinson's disease. Long-term outlook Early detection of Parkinson's disease is key to helping reduce complications that can negatively affect the outlook. If you suspect that you or a loved one may have Parkinson's disease, consult a doctor right away. Parkinson's symptoms and severity by stage Doctors classify Parkinson's disease into stages 1 to 5, with stage 5 being the most advanced. Advanced stages may increase the risk of health complications that can reduce life span. The symptoms of Parkinson's are gradual and are sometimes not noticeable in the early stages of the disease. They may include: tremors loss of balance slowing of movements spontaneous, uncontrollable movements Symptoms in later stages of Parkinson's may include: more frequent falls trouble dressing difficulty eating swallowing severe stiffness in your legs, which makes it impossible to stand or walk hallucinations or delusions cognitive changes (problems with planning, language, attention, or memory) dementia lightheadedness mood disorders loss of sense of smell or taste vision problems sleep disorders sexual problems As Parkinson's progresses to stages 3, 4, and 5, the risk of falling may increase, and motor balance may worsen. Pneumonia, particularly aspiration pneumonia, is the leading cause of death for people with Parkinson's, accounting for 70% of Parkinson's deaths. Aspiration pneumonia happens when you inhale food, stomach acid, or saliva into the lungs. As Parkinson's progresses, swallowing can become more difficult, causing food and liquid to enter the lungs. Treatment may help reduce symptoms. Frequently asked questions Why does it take so long for a diagnosis of Parkinson's disease? There is no definitive medical test that can be performed to diagnose Parkinson's disease. It's essentially a clinical diagnosis, meaning a doctor will make the diagnosis based on several clinical features seen. Symptoms of Parkinson's disease include tremor, slowness of movement, stiffness, and balance problems. However, the presentation and progression of these symptoms vary widely from person to person. The initial presentation is often subtle and may be similar to other conditions. Some people think their symptoms are due to normal aging, which may make them delay seeking medical attention. Another common finding in patients with Parkinson's disease is 'masked facies,' or an expressionless face, which often gets mistaken for depression. If there's concern that someone is developing Parkinson's disease, they should get a clinical exam from a neurologist to get a diagnosis. There is no definitive medical test that can be performed to diagnose Parkinson's disease. It's essentially a clinical diagnosis, meaning a doctor will make the diagnosis based on several clinical features seen. Symptoms of Parkinson's disease include tremor, slowness of movement, stiffness, and balance problems. However, the presentation and progression of these symptoms vary widely from person to person. The initial presentation is often subtle and may be similar to other conditions. Some people think their symptoms are due to normal aging, which may make them delay seeking medical attention. Another common finding in patients with Parkinson's disease is 'masked facies,' or an expressionless face, which often gets mistaken for depression. If there's concern that someone is developing Parkinson's disease, they should get a clinical exam from a neurologist to get a diagnosis. Is Parkinson's disease fatal? While Parkinson's disease is not fatal, it can cause complications that increase the risk of death. People with Parkinson's have a mortality rate 3 times that of people without Parkinson's. While Parkinson's disease is not fatal, it can cause complications that increase the risk of death. People with Parkinson's have a mortality rate 3 times that of people without Parkinson's. Can treatment help prevent Parkinson's disease complications? Parkinson's disease cannot be cured, but medications, supportive treatments, lifestyle changes, and even surgery can help manage your symptoms or delay more severe symptoms, especially if you start treatment early. This may reduce complications. Parkinson's disease cannot be cured, but medications, supportive treatments, lifestyle changes, and even surgery can help manage your symptoms or delay more severe symptoms, especially if you start treatment early. This may reduce complications.
Fox News
2 hours ago
- Fox News
Far-left House candidate rallies around healthcare for illegal immigrants: 'How is it controversial?'
Kat Abughazaleh, a 26-year-old Democratic candidate for Illinois' ninth congressional district in the U.S. House of Representatives, said "every single person in the world deserves healthcare," even illegal immigrants. "How is it controversial?" Abughazaleh asked a CNN "NewsNight" panel on Thursday night. The young progressive candidate, with a campaign website that reads, "I don't have health insurance, and I'm running for Congress," repeatedly told the panel that every person is entitled to healthcare when asked if that includes illegal immigrants. "I'm such a monster… How is it controversial that I don't want someone to die in the hospital if they can't afford it?" Abughazaleh asked. President Donald Trump's One Big Beautiful Bill Act is currently under consideration by a Republican-led White House and Congress. The president has championed the legislation as fulfilling his key campaign promises, including border security, American energy production and tax cuts. House Republicans have celebrated Medicaid reform included in the megabill, which they say eliminates waste, fraud and abuse in the welfare program to deliver for Americans who need coverage most. Removing illegal immigrants from Medicaid is one of the key provisions of that Medicaid reform. Meanwhile, Democrats have railed against possible Medicaid cuts since Trump was elected in November. Every House Democrat voted against the bill, and Democrats are already defining Medicaid cuts as a driving issue ahead of competitive midterm elections in 2026. The bill does not cut Medicaid for the most vulnerable, according to Rep. Erin Houchin, R-Ind., who served on three major committees leading budget markup in the reconciliation process. Houchin told Fox News Digital that targeting waste, fraud and abuse in the Medicaid program cuts benefits to illegal immigrants, those ineligible to receive benefits who are currently receiving benefits, duplicate enrollees in one or more states and those who are able-bodied but are choosing not to work. "Your bill is going to cut coverage for 11 million Americans and it'll still cost more than universal healthcare. Healthcare is a human right, you absolute ghouls," Abughazaleh said in response to a Republican National Committee (RNC) rapid response account calling her comments, "madness." Abughazaleh said she is running for the U.S. House of Representatives because, "Our leaders are out of touch." The young Democrat is challenging Rep. Jan Schakowsky, D-Ill., who has served decades in congress. Abughazaleh is a former staffer for the progressive watchdog group, Media Matters, and a progressive influencer.
